Pantozol (Pantoprazole)

Pantoprazole, the active ingredient in Pantozol, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid secretion and is used to treat acid‑related gastrointestinal conditions in adults.

GNH USA supplies Pantozol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton pump inhibitor indicated for several acid‑related gastrointestinal disorders. - Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of esophageal erosion. - Erosive esophagitis: accelerates mucosal healing and reduces symptom recurrence. - Peptic ulcer disease: supports ulcer healing and maintenance of remission, often as part of H. pylori eradication regimens. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors. - NSAID‑induced ulcer prophylaxis: reduces the risk of ulcer formation in patients requiring chronic non‑steroidal anti‑inflammatory therapy.

Common Side Effects: - Headache: mild to moderate pain often transient. - Diarrhea: loose stools that may resolve with continued therapy. - Nausea: feeling of queasiness, usually mild. - Abdominal pain: discomfort in the stomach area. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: severe diarrhea and colitis. - Hypomagnesemia: low magnesium levels causing muscle cramps or arrhythmias. - Bone fractures: increased risk with long‑term use. - Acute interstitial nephritis: kidney inflammation presenting with fever and rash. - Stevens‑Johnson syndrome: rare skin blistering disorder.

Pantoprazole should be used with clinical oversight and consideration of patient‑specific factors. - Renal function assessment: dose adjustment may be required in severe impairment. - Monitor magnesium: prolonged therapy can lead to hypomagnesemia; check levels periodically. - Discontinue cautiously: abrupt cessation may cause rebound acid hypersecretion. - Hepatic impairment: use with caution in patients with liver disease. - Pregnancy and lactation: only if clearly needed; discuss risks with a healthcare professional. - Store at room temperature: keep in the original container, protect from moisture and light.

Pantoprazole may interact with several medicines, altering their effectiveness or safety. Major Interactions (Avoid): - Atazanavir: reduced absorption of the antiviral, compromising HIV therapy. - Nelfinavir: decreased plasma levels, reducing antiviral efficacy. - Rilpivirine: impaired absorption, leading to subtherapeutic exposure. - Clopidogrel: reduced activation, potentially diminishing antiplatelet effect. Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR; monitor coagulation parameters. - Digoxin: may raise serum levels; check renal function and digoxin concentrations. - Methotrexate: reduced clearance can raise toxicity risk; monitor blood counts. - Fluconazole: may increase pantoprazole levels; observe for enhanced effects. - HIV protease inhibitors (e.g., ritonavir): may alter metabolism; adjust dosing as needed.